Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans

By Ghotbi Roza   Christensen Magnus   Roh Hyung-Keun   Ingelman-Sundberg Magnus   Aklillu Eleni   Bertilsson Leif  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 6, 2007-06 ,pp. : 537-546

Springer Publishing Company

Access to resources Recommend Favorite

Challenges in CYP2D6 Phenotype Assignment from Genotype Data: A Critical Assessment and Call for Standardization

By  

Current Drug Metabolism, Vol. 15, Iss. 2, 2014-02 ,pp. : 218-232

Bentham Science Publishers

Access to resources Recommend Favorite

The influence of dose and N-acetyltransferase-2 (NAT2) genotype and phenotype on the pharmacokinetics and pharmacodynamics of isoniazid

By Donald P.   Parkin D.   Seifart H.   Schaaf H.   Helden P.   Werely C.   Sirgel F.   Venter A.   Maritz J.  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 7, 2007-07 ,pp. : 633-639

Springer Publishing Company

Access to resources Recommend Favorite

Smoking impact on CYP1A2 activity in a group of patients with schizophrenia

By Bozikas V.P.   Papakosta M.   Niopas I.   Karavatos A.   Mirtsou-Fidani V.  

European Neuropsychopharmacology, Vol. 14, Iss. 1, 2004-01 ,pp. : 39-44

Elsevier

Access to resources Recommend Favorite

Olanzapine: An Updated Review of its Use in the Management of Schizophrenia

By Bhana N.   Foster R.H.   Olney R.   Plosker G.L.  

Drugs, Vol. 61, Iss. 1, 2001-01 ,pp. : 111-161

Adis International

Access to resources Recommend Favorite